The core activity of CK-CARE is the research and development of therapies for rare diseases, particularly atopic dermatitis (neurodermatitis), through high-quality research in a scientific network in the field of allergology. The company focuses on collecting and evaluating data and samples in a biobank to enable a better understanding of complex diseases and develop innovative therapies and prevention strategies.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Research focus on atopic dermatitis, allergies and their interrelationships; development of new therapeutic and prevention approaches, as well as evidence-based strategies to curb allergic diseases.
Data and biobank
Collection and use of clinical data, blood, skin and microbiome samples for long-term observation of atopic dermatitis and allergies, as well as for identifying new subgroups.
Education and further training in allergology
Knowledge transfer for physicians and other care providers, learning programmes for implementation in practice, and the promotion of skills and performance capacity.
Global Allergy Forum (GAF)
Professional forum and exchange platform in the field of allergology, linked to research, networking and knowledge transfer.
Studies in allergy research
Clinical studies such as the Pro-RaD study and the CARE study for recruiting patients and investigating atopic dermatitis and allergies.